Replies to post #98170 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

That's 40% premium from the last close. I hope Elanco will not shelf AT-014, and finds a way to deliver it the markets after a full approval. At least, this program is listed on the "best-in-class" Aratana portfolio lis


PETX got bought out, leaving big brother(not long ago)ADXS, rolling in the dust.